Literature DB >> 14512173

Cytokine producing CD8+ T cells are correlated to MRI features of tissue destruction in MS.

Joep Killestein1, M Judith Eikelenboom, Thijs Izeboud, Nynke F Kalkers, Herman J Adèr, Frederik Barkhof, Rene A W Van Lier, Bernard M J Uitdehaag, Chris H Polman.   

Abstract

Specific T-cell subsets and their ability to produce cytokines have been involved in concepts of multiple sclerosis (MS) pathogenesis. Evidence to link cytokine producing T-cell subsets to magnetic resonance imaging (MRI) features of tissue destruction, however, is limited. Cytokine flow cytometry was performed in 124 patients with different subtypes of MS. In a subgroup of 69 patients, from whom longitudinal MRI was available, the ability of circulating types 1 and 2 helper T cells to produce cytokines was correlated to changes in T1 hypointense and T2 hyperintense lesion load (LL) on brain MRI during 3 years of follow-up. Significant negative correlations were found between baseline CD8(+) T-cell subsets producing IL-2, IL-4 or IL-13 and the change in T1 LL. Subgroup analyses demonstrated that in RRMS, CD8(+) T cells producing IL-2, IL-4 or IL-13, and in PPMS, CD8(+) IL-10(+) T cells correlated negatively with T1 LL. To our knowledge, this study provides the first direct immunophenotypic evidence of cytokine producing CD8(+) T cells being directly related to long-term development of MRI features of demyelination and axonal loss.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512173     DOI: 10.1016/s0165-5728(03)00265-0

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

1.  High-Resolution Expression Profiling of Peripheral Blood CD8+ Cells in Patients with Multiple Sclerosis Displays Fingolimod-Induced Immune Cell Redistribution.

Authors:  Luisa Roch; Michael Hecker; Jörg Friess; Ines Charlotte Angerer; Dirk Koczan; Brit Fitzner; Ina Schröder; Kristin Flechtner; Hans-Jürgen Thiesen; Stefanie Meister; Alexander Winkelmann; Uwe Klaus Zettl
Journal:  Mol Neurobiol       Date:  2016-09-08       Impact factor: 5.590

Review 2.  Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models.

Authors:  Lennart T Mars; Philippe Saikali; Roland S Liblau; Nathalie Arbour
Journal:  Biochim Biophys Acta       Date:  2010-07-15

3.  Relapsing-remitting central nervous system autoimmunity mediated by GFAP-specific CD8 T cells.

Authors:  Katsuhiro Sasaki; Angela Bean; Shivanee Shah; Elizabeth Schutten; Priya G Huseby; Bjorn Peters; Zu T Shen; Vijay Vanguri; Denny Liggitt; Eric S Huseby
Journal:  J Immunol       Date:  2014-03-03       Impact factor: 5.422

4.  Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood.

Authors:  Christian Skulina; Stephan Schmidt; Klaus Dornmair; Holger Babbe; Axel Roers; Klaus Rajewsky; Hartmut Wekerle; Reinhard Hohlfeld; Norbert Goebels
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

5.  RNA-Binding Protein Expression Alters Upon Differentiation of Human B Cells and T Cells.

Authors:  Nordin D Zandhuis; Benoit P Nicolet; Monika C Wolkers
Journal:  Front Immunol       Date:  2021-11-17       Impact factor: 7.561

6.  Pathogenic CD8 T cells in multiple sclerosis and its experimental models.

Authors:  Eric S Huseby; Priya G Huseby; Shivanee Shah; Rebecca Smith; Brian D Stadinski
Journal:  Front Immunol       Date:  2012-03-29       Impact factor: 7.561

7.  An antigen-specific pathway for CD8 T cells across the blood-brain barrier.

Authors:  Ian Galea; Martine Bernardes-Silva; Penny A Forse; Nico van Rooijen; Roland S Liblau; V Hugh Perry
Journal:  J Exp Med       Date:  2007-08-06       Impact factor: 14.307

Review 8.  Role of T cell-glial cell interactions in creating and amplifying central nervous system inflammation and multiple sclerosis disease symptoms.

Authors:  Eric S Huseby; Daisuke Kamimura; Yasunobu Arima; Caitlin S Parello; Katsuhiro Sasaki; Masaaki Murakami
Journal:  Front Cell Neurosci       Date:  2015-08-05       Impact factor: 5.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.